Has Vipul Sharma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,537 in general payments to Vipul Sharma, MD across 92 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vipul Sharma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vipul Sharma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vipul Sharma, MD

Interventional Pain Medicine · Hamburg, PANPI 1538504949

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,937, more than ten times the $25 reported in 2019.

$4,537in general payments, 2019–2025

Across 92 payments — averaging $49.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$1K
Saluda Medical Americas, Inc.$644
Curonix LLC$439
Medtronic$384
Si-bone, Inc.$372
Boston Scientific$307
plus $1K from 12 others

What the payments were for

Food & beverage$4,537100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	23	$1,065
Saluda Medical Americas, Inc.	11	$644
Curonix LLC	10	$439
Medtronic(2 entities)	9	$384
Si-bone, Inc.	4	$372
Boston Scientific	6	$307
SPR Therapeutics, Inc	7	$218
Stryker	3	$198
Globus Medical	2	$178
Vertos Medical, Inc.	2	$163
Nevro Corp.	2	$154
Eisai Inc.	1	$123
Foundation Fusion Solutions, LLC	5	$99
Angiodynamics, Inc.	1	$66
AbbVie	2	$54
Electronic Waveform Lab, Inc.	2	$25
DJO, LLC	1	$25
Xeris Pharmaceuticals, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Evoke$433
PROCLAIM$420
ETERNA$262
Senza$260
mild Device Kit$246
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$217
INTELLIS ADAPTIVESTIM$169
Leqembi$123
GENERAL PAIN MANAGEMENT$104
SPRINT PNS System$101

How this compares

$4,537 in reported general payments places this provider in the 60th percentile of 59 interventional pain medicine providers in Pennsylvania.

See all interventional pain medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$132,192

Medicare patients

299

Services billed

2,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	42	$6,311
Pregabalin	51	$2,394
Gabapentin	129	$2,227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	35	$774
Oxycodone Hcl	24	$743
Cyclobenzaprine Hcl	43	$743
Tizanidine Hcl	25	$580
Duloxetine Hcl	19	$490
Acetaminophen-CodeineAcetaminophen With Codeine	26	$424
Methocarbamol	21	$368
Baclofen	25	$348
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$193
Tramadol Hcl	41	$186
Meloxicam	26	$151
Lorazepam	16	$59

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Hamburg

Michael FishmanLebanon$670K
David ProvenzanoSewickley$198K
Michael FarrellPittsburgh$23K
Farshad RashidianWest Chester$19K
Chad MetzgerDarby$14K
Jorge Rivero-BecerraPittsburgh$12K
James BresnahanSpringfield$12K
Jonathan SchollIndiana$11K
Nathan MaltezosWest Chester$10K
Mark BellPlains$9K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →